[ad_1]
Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
[ad_2]
Funding lifelines: How to cross the 'valley of death'
Related Posts
Ecommerce retailer Japanet quadruples size of VC fund to $200m after AI wins
[ad_1] After a successful string of investments, the corporate boosts corporate venture capital fund. Japanese home shopping retailer Japanet has expanded its corporate VC fund, […]
The VC Landscape In 2025: Key Trends That Shaped The Year
[ad_1] AI mega-rounds, fewer seed deals, and private equity’s rise are redefining venture capital in 2025. What founders need to know now. [ad_2]
Galaxy: The top seven deals accounted for nearly half of Q3 investment activity, suggesting the golden age of pre-seed round investing may be over.
[ad_1] Galaxy Digital research report pointed out that in the third quarter of this year, seven large transactions raised more than $2.26 billion, accounting for […]